Fatal invasive pulmonary aspergillosis associated with adalimumab therapy

Gut

Volumn 58, Issue 1, 2009, Pages 149-

  Manz, M ^a   Beglinger, C ^a   Vavricka, S R ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CASE REPORT; CAUSE OF DEATH; COUGHING; CROHN DISEASE; DISEASE SEVERITY; DRUG INDUCED DISEASE; DYSPNEA; FEMALE; FEVER; HUMAN; HYPOTENSION; INFECTION RISK; KIDNEY FAILURE; LETTER; LEUKOCYTOSIS; LUNG ASPERGILLOSIS; MAINTENANCE THERAPY; METABOLIC ACIDOSIS; MONOTHERAPY; PRIORITY JOURNAL; RESPIRATORY FAILURE; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; FATALITY; NOTE; OPPORTUNISTIC INFECTION;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FATAL OUTCOME; FEMALE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; OPPORTUNISTIC INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58249089524     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.161638     Document Type: Letter

References (3)

1. Tsiodras S, Samonis G, Boumpas DT, et al. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008; 83:181-94.
2. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001; 344:1099-100.
3. Mehrad B, Strieter RM, Standrford TJ. Role of TNF- alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol 1999; 162:1633-40.